Vanderbilt researchers on guanfacine for hyperadrenergic patients, Pamela Roff, B.S. posted on the topic
$ 8.50 · 4.6 (738) · In stock
Vanderbilt researchers recently presented new data on the use of guanfacine in 47 hyperadrenergic #POTS patients. They note that 72% of patients responded well…
Brian Robert Tees, MBA on LinkedIn: Transplant Genomics is taking the mission to Capitol Hill! This week, key…
Pamela Roff, B.S. - Provider Relations - South Denver Cardiology Associates
Pamela Roff, B.S. on LinkedIn: CALLING ALL RESEARCHERS! Dysautonomia International is now accepting grant…
Pamela Roff, B.S. on LinkedIn: I'm excited to announce that I've accepted a new position as Provider…
Vanderbilt researchers on guanfacine for hyperadrenergic patients, Pamela Roff, B.S. posted on the topic
Vanderbilt researchers on guanfacine for hyperadrenergic patients, Pamela Roff, B.S. posted on the topic
Brian Robert Tees, MBA on LinkedIn: Transplant Genomics is taking the mission to Capitol Hill! This week, key…
Silvia De Rosa on LinkedIn: Acute Kidney Injury (AKI) and Blood Purification Therapy Survey
Silvia De Rosa on LinkedIn: Acute Kidney Injury (AKI) and Blood Purification Therapy Survey
Silvia De Rosa on LinkedIn: Acute Kidney Injury (AKI) and Blood Purification Therapy Survey